Market News
GW Pharma stock rises after reporting earnings results for the quarter ended Dec. 31, 2018
As GW Pharmaceuticals (GWPH) moved its fiscal year beginning to January 1, 2019, the company reported financial results for the quarter…
Splunk soars to all-time high ahead of Q4 earnings
Splunk Inc. (SPLK) stock soared to an all-time of $137.07 on Tuesday ahead of its fourth-quarter earnings on Thursday after…
Palo Alto reports stellar Q2 results, unveils $1 billion share repurchase plan
Palo Alto Networks (NYSE: PANW) reported better-than-expected Q2 earnings continuing the strong momentum from the last quarter. The board also…
Earnings Preview: Global sales might save Budweiser maker AB InBev in Q4 from US slump
International beer giant Anheuser-Busch InBev SA (BUD), better known as AB InBev, is scheduled to post its fourth-quarter 2018 results…
Caterpillar stock sinks after double downgrade by UBS, citing construction slump
The current slowdown in building activity across major markets, amid softening economic growth, is taking a toll on the construction…
Cracker Barrel stock in red despite Q2 earnings beat
Shares of the Cracker Barrel Old Country Store (Nasdaq: CBRL) were down about 2% after the markets opened primarily due…
Bank of Nova Scotia lifts dividend; Q1 earnings slip amid market volatility
Reflecting the volatile market conditions, Bank of Nova Scotia (BNS) Tuesday reported a decline in its first-quarter earnings which also…
Zynerba Pharmaceuticals stock soars on receiving US patent for its CBD gel to treat Fragile X syndrome
Cannabinoid therapeutics developer Zynerba Pharmaceuticals (ZYNE) received US patent named “Treatment of Fragile X Syndrome with Cannabidiol”. Shares of Zynerba soared…